Personalised prediction of the individual risk of liver-related events in MASLD using the dynamics of non-invasive tests.
BACKGROUND AND AIMS The evolution of non-invasive tests of liver fibrosis during follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) remains difficult to interpret in clinical practice. We aimed to translate the dynamics of non-invasive tests into a personalized prediction of liv...